Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2011 Aug;11(4):312-6.
doi: 10.7861/clinmedicine.11-4-312.

Including pharmacists on consultant-led ward rounds: a prospective non-randomised controlled trial

Gavin Miller  1 , Bryony Dean Franklin, Ann Jacklin
Affiliations
Controlled Clinical Trial

Including pharmacists on consultant-led ward rounds: a prospective non-randomised controlled trial

Gavin Miller et al. Clin Med (Lond). 2011 Aug.

Abstract

This study aimed to compare interventions made by pharmacists attending consultant-led ward rounds in addition to providing a ward pharmacy service, with those made by pharmacists providing a word pharmacy service alone. A prospective non-randomised controlled study on five inpatient medical wards was carried out at two teaching hospitals. A mean of 1.73 physician-accepted interventions were made per patient for the study group, compared to 0.89 for the control (Mann Whitney U, p < 0.001) with no difference between groups in the nature or clinical importance of the interventions. One physician-accepted intervention was made every eight minutes during the consultant-led ward rounds, compared to one every 63 minutes during a ward pharmacist visit. Pharmacists attending consultant-led ward rounds in addition to undertaking a ward pharmacist visit make significantly more interventions per patient than those made by pharmacists undertaking a ward pharmacist visit alone, rectifying prescribing errors and optimising treatment.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Types of interventions made.
See this image and copyright information in PMC

Comment in

References

    1. Stebbing C, Jacklin A, Barber N, Bates D. A comparison of the US and UK inpatient medication systems. Eur J Hosp Pharm Practice. 2006;12:36–40.
    1. Farrar K, Stoddart M, Slee A. Clinical pharmacy and reactive prescription review–time for a change? Pharm J. 1998;260:759–61.
    1. Bates D, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29–34. doi: 10.1001/jama.1995.03530010043033. - DOI - PubMed
    1. Kucukarslan S, Peters M, Mlynarek M, Nafziger D. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8. doi: 10.1001/archinte.163.17.2014. - DOI - PubMed
    1. Leape L, Cullen D, Clapp M, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;281:267–70. doi: 10.1001/jama.282.3.267. - DOI - PubMed

Publication types

MeSH terms